Selected research
Industry Growth & Trends
Global Gliquidone Industry Growth and Trends Forecast to 2032
Market perspective
The global Gliquidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gliquidone include Boehringer Ingelheim, Dexa Medica, Menarini Belgium, CR Double-Crane, Jinheng Pharma, Vanguard Pharma, Yiling Pharma and TIPR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Gliquidone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Gliquidone market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gliquidone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gliquidone.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Gliquidone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Gliquidone Market by Company
Boehringer Ingelheim
Dexa Medica
Menarini Belgium
CR Double-Crane
Jinheng Pharma
Vanguard Pharma
Yiling Pharma
TIPR
Gliquidone Segment by Type
Glequinone Tablets
Glequinone Capsule
Glequinone Sustained Release Tablets
Others
Gliquidone Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Gliquidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliquidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gliquidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliquidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gliquidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Gliquidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glequinone Tablets
- Glequinone Capsule
- Glequinone Sustained Release Tablets
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Boehringer Ingelheim
- Dexa Medica
- Menarini Belgium
- CR Double-Crane
- Jinheng Pharma
- Vanguard Pharma
- Yiling Pharma
- TIPR
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Gliquidone Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Gliquidone Sales Estimates and Forecasts (2021-2032)
- 1.3 Gliquidone Market by Type
- 1.3.1 Glequinone Tablets
- 1.3.2 Glequinone Capsule
- 1.3.3 Glequinone Sustained Release Tablets
- 1.3.4 Others
- 1.4 Global Gliquidone Market Size by Type
- 1.4.1 Global Gliquidone Market Size Overview by Type (2021-2032)
- 1.4.2 Global Gliquidone Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Gliquidone Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Gliquidone Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Gliquidone Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Gliquidone Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Gliquidone Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Gliquidone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Gliquidone Industry Trends
- 2.2 Gliquidone Industry Drivers
- 2.3 Gliquidone Industry Opportunities and Challenges
- 2.4 Gliquidone Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Gliquidone Revenue (2021-2026)
- 3.2 Global Top Players by Gliquidone Sales (2021-2026)
- 3.3 Global Top Players by Gliquidone Price (2021-2026)
- 3.4 Global Gliquidone Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gliquidone Major Company Production Sites & Headquarters
- 3.6 Global Gliquidone Company, Product Type & Application
- 3.7 Global Gliquidone Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gliquidone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gliquidone Players Market Share by Revenue in 2025
- 3.8.3 2025 Gliquidone Tier 1, Tier 2, and Tier 3
4 Gliquidone Regional Status and Outlook
- 4.1 Global Gliquidone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Gliquidone Historic Market Size by Region
- 4.2.1 Global Gliquidone Sales in Volume by Region (2021-2026)
- 4.2.2 Global Gliquidone Sales in Value by Region (2021-2026)
- 4.2.3 Global Gliquidone Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Gliquidone Forecasted Market Size by Region
- 4.3.1 Global Gliquidone Sales in Volume by Region (2027-2032)
- 4.3.2 Global Gliquidone Sales in Value by Region (2027-2032)
- 4.3.3 Global Gliquidone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gliquidone by Application
- 5.1 Gliquidone Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Gliquidone Market Size by Application
- 5.2.1 Global Gliquidone Market Size Overview by Application (2021-2032)
- 5.2.2 Global Gliquidone Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Gliquidone Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Gliquidone Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Gliquidone Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Gliquidone Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Gliquidone Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Gliquidone Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Boehringer Ingelheim
- 6.1.1 Boehringer Ingelheim Company Information
- 6.1.2 Boehringer Ingelheim Business Overview
- 6.1.3 Boehringer Ingelheim Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Boehringer Ingelheim Gliquidone Product Portfolio
- 6.1.5 Boehringer Ingelheim Recent Developments
- 6.2 Dexa Medica
- 6.2.1 Dexa Medica Company Information
- 6.2.2 Dexa Medica Business Overview
- 6.2.3 Dexa Medica Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Dexa Medica Gliquidone Product Portfolio
- 6.2.5 Dexa Medica Recent Developments
- 6.3 Menarini Belgium
- 6.3.1 Menarini Belgium Company Information
- 6.3.2 Menarini Belgium Business Overview
- 6.3.3 Menarini Belgium Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Menarini Belgium Gliquidone Product Portfolio
- 6.3.5 Menarini Belgium Recent Developments
- 6.4 CR Double-Crane
- 6.4.1 CR Double-Crane Company Information
- 6.4.2 CR Double-Crane Business Overview
- 6.4.3 CR Double-Crane Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 CR Double-Crane Gliquidone Product Portfolio
- 6.4.5 CR Double-Crane Recent Developments
- 6.5 Jinheng Pharma
- 6.5.1 Jinheng Pharma Company Information
- 6.5.2 Jinheng Pharma Business Overview
- 6.5.3 Jinheng Pharma Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Jinheng Pharma Gliquidone Product Portfolio
- 6.5.5 Jinheng Pharma Recent Developments
- 6.6 Vanguard Pharma
- 6.6.1 Vanguard Pharma Company Information
- 6.6.2 Vanguard Pharma Business Overview
- 6.6.3 Vanguard Pharma Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Vanguard Pharma Gliquidone Product Portfolio
- 6.6.5 Vanguard Pharma Recent Developments
- 6.7 Yiling Pharma
- 6.7.1 Yiling Pharma Company Information
- 6.7.2 Yiling Pharma Business Overview
- 6.7.3 Yiling Pharma Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Yiling Pharma Gliquidone Product Portfolio
- 6.7.5 Yiling Pharma Recent Developments
- 6.8 TIPR
- 6.8.1 TIPR Company Information
- 6.8.2 TIPR Business Overview
- 6.8.3 TIPR Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 TIPR Gliquidone Product Portfolio
- 6.8.5 TIPR Recent Developments
7 North America by Country
- 7.1 North America Gliquidone Sales by Country
- 7.1.1 North America Gliquidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Gliquidone Sales by Country (2021-2026)
- 7.1.3 North America Gliquidone Sales Forecast by Country (2027-2032)
- 7.2 North America Gliquidone Market Size by Country
- 7.2.1 North America Gliquidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Gliquidone Market Size by Country (2021-2026)
- 7.2.3 North America Gliquidone Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Gliquidone Sales by Country
- 8.1.1 Europe Gliquidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Gliquidone Sales by Country (2021-2026)
- 8.1.3 Europe Gliquidone Sales Forecast by Country (2027-2032)
- 8.2 Europe Gliquidone Market Size by Country
- 8.2.1 Europe Gliquidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Gliquidone Market Size by Country (2021-2026)
- 8.2.3 Europe Gliquidone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Gliquidone Sales by Country
- 9.1.1 Asia-Pacific Gliquidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Gliquidone Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Gliquidone Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Gliquidone Market Size by Country
- 9.2.1 Asia-Pacific Gliquidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Gliquidone Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Gliquidone Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Gliquidone Sales by Country
- 10.1.1 South America Gliquidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Gliquidone Sales by Country (2021-2026)
- 10.1.3 South America Gliquidone Sales Forecast by Country (2027-2032)
- 10.2 South America Gliquidone Market Size by Country
- 10.2.1 South America Gliquidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Gliquidone Market Size by Country (2021-2026)
- 10.2.3 South America Gliquidone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Gliquidone Sales by Country
- 11.1.1 Middle East and Africa Gliquidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Gliquidone Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Gliquidone Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Gliquidone Market Size by Country
- 11.2.1 Middle East and Africa Gliquidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Gliquidone Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Gliquidone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Gliquidone Value Chain Analysis
- 12.1.1 Gliquidone Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Gliquidone Production Mode & Process
- 12.2 Gliquidone Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Gliquidone Distributors
- 12.2.3 Gliquidone Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst